Annual Current Liabilities
$27.23 B
+$386.65 M+1.44%
December 1, 2024
Summary
- As of February 22, 2025, GSK annual total current liabilities is $27.23 billion, with the most recent change of +$386.65 million (+1.44%) on December 1, 2024.
- During the last 3 years, GSK annual current liabilities has fallen by -$4.72 billion (-14.78%).
- GSK annual current liabilities is now -24.18% below its all-time high of $35.91 billion, reached on December 31, 2017.
Performance
GSK Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$27.23 B
-$1.49 B-5.19%
December 1, 2024
Summary
- As of February 22, 2025, GSK quarterly total current liabilities is $27.23 billion, with the most recent change of -$1.49 billion (-5.19%) on December 1, 2024.
- Over the past year, GSK quarterly current liabilities has stayed the same.
- GSK quarterly current liabilities is now -40.67% below its all-time high of $45.89 billion, reached on June 30, 2022.
Performance
GSK Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
GSK Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.4% | 0.0% |
| 3 y3 years | -14.8% | -14.6% |
| 5 y5 years | -13.7% | -14.6% |
GSK Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.8% | +1.4% | -40.7% | +16.4% |
| 5 y | 5-year | -14.8% | +1.4% | -40.7% | +16.4% |
| alltime | all time | -24.2% | +4815.1% | -40.7% | +3082.2% |
GSK Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $27.23 B(+1.4%) | $27.23 B(-5.2%) |
| Sep 2024 | - | $28.72 B(+11.6%) |
| Jun 2024 | - | $25.73 B(+2.7%) |
| Mar 2024 | - | $25.06 B(-6.6%) |
| Dec 2023 | $26.84 B(-2.8%) | $26.84 B(-1.8%) |
| Sep 2023 | - | $27.32 B(-2.0%) |
| Jun 2023 | - | $27.89 B(+8.8%) |
| Mar 2023 | - | $25.63 B(-7.1%) |
| Dec 2022 | $27.60 B(-13.6%) | $27.60 B(+18.0%) |
| Sep 2022 | - | $23.40 B(-49.0%) |
| Jun 2022 | - | $45.89 B(+43.9%) |
| Mar 2022 | - | $31.89 B(-0.2%) |
| Dec 2021 | $31.95 B(+5.8%) | $31.95 B(+6.1%) |
| Sep 2021 | - | $30.10 B(+1.7%) |
| Jun 2021 | - | $29.60 B(+6.2%) |
| Mar 2021 | - | $27.87 B(-7.7%) |
| Dec 2020 | $30.18 B(-4.3%) | $30.18 B(+5.8%) |
| Sep 2020 | - | $28.53 B(-3.1%) |
| Jun 2020 | - | $29.45 B(-6.0%) |
| Mar 2020 | - | $31.34 B(-0.6%) |
| Dec 2019 | $31.53 B(+10.5%) | $31.53 B(+0.5%) |
| Sep 2019 | - | $31.36 B(-4.0%) |
| Jun 2019 | - | $32.67 B(+2.4%) |
| Mar 2019 | - | $31.90 B(+11.8%) |
| Dec 2018 | $28.54 B(-20.5%) | $28.54 B(+19.1%) |
| Sep 2018 | - | $23.97 B(+0.7%) |
| Jun 2018 | - | $23.79 B(-37.0%) |
| Mar 2018 | - | $37.74 B(+5.1%) |
| Dec 2017 | $35.91 B(+53.8%) | $35.91 B(-2.6%) |
| Sep 2017 | - | $36.85 B(-1.6%) |
| Jun 2017 | - | $37.45 B(+60.0%) |
| Mar 2017 | - | $23.40 B(+0.3%) |
| Dec 2016 | $23.34 B(+17.4%) | $23.34 B(-0.7%) |
| Sep 2016 | - | $23.51 B(-3.5%) |
| Jun 2016 | - | $24.38 B(+21.9%) |
| Mar 2016 | - | $20.00 B(+0.6%) |
| Dec 2015 | $19.88 B(-3.9%) | $19.88 B(+2.9%) |
| Sep 2015 | - | $19.32 B(-10.9%) |
| Jun 2015 | - | $21.69 B(-7.2%) |
| Mar 2015 | - | $23.38 B(+13.0%) |
| Dec 2014 | $20.69 B(-8.2%) | $20.69 B(-16.6%) |
| Sep 2014 | - | $24.80 B(+18.8%) |
| Jun 2014 | - | $20.87 B(+7.5%) |
| Mar 2014 | - | $19.42 B(-13.9%) |
| Dec 2013 | $22.55 B(+1.0%) | $22.55 B(+8.7%) |
| Sep 2013 | - | $20.74 B(+9.0%) |
| Jun 2013 | - | $19.03 B(+4.3%) |
| Mar 2013 | - | $18.25 B(-18.3%) |
| Dec 2012 | $22.33 B(-3.5%) | $22.33 B(-1.5%) |
| Sep 2012 | - | $22.66 B(-5.2%) |
| Jun 2012 | - | $23.90 B(+3.1%) |
| Mar 2012 | - | $23.19 B(+0.3%) |
| Dec 2011 | $23.13 B(+17.1%) | $23.13 B(+13.2%) |
| Sep 2011 | - | $20.44 B(-6.6%) |
| Jun 2011 | - | $21.89 B(+3.9%) |
| Mar 2011 | - | $21.07 B(+6.7%) |
| Dec 2010 | $19.75 B(+0.8%) | $19.75 B(+11.2%) |
| Sep 2010 | - | $17.76 B(-1.0%) |
| Jun 2010 | - | $17.93 B(-2.8%) |
| Mar 2010 | - | $18.45 B(-5.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $19.60 B(+33.6%) | $19.60 B(+10.1%) |
| Sep 2009 | - | $17.79 B(+19.6%) |
| Jun 2009 | - | $14.87 B(+6.4%) |
| Mar 2009 | - | $13.98 B(-4.7%) |
| Dec 2008 | $14.67 B(-28.7%) | $14.67 B(-6.4%) |
| Sep 2008 | - | $15.67 B(-4.8%) |
| Jun 2008 | - | $16.47 B(-10.5%) |
| Mar 2008 | - | $18.41 B(-10.5%) |
| Dec 2007 | $20.57 B(+44.6%) | $20.57 B(+11.4%) |
| Sep 2007 | - | $18.46 B(+27.6%) |
| Jun 2007 | - | $14.47 B(-1.2%) |
| Mar 2007 | - | $14.64 B(+3.0%) |
| Dec 2006 | $14.22 B(-13.0%) | $14.22 B(+4.2%) |
| Sep 2006 | - | $13.65 B(-10.4%) |
| Jun 2006 | - | $15.24 B(-6.1%) |
| Mar 2006 | - | $16.24 B(-0.7%) |
| Dec 2005 | $16.35 B(+1.4%) | $16.35 B(-1.7%) |
| Sep 2005 | - | $16.64 B(+1.7%) |
| Jun 2005 | - | $16.37 B(-5.2%) |
| Mar 2005 | - | $17.27 B(+7.0%) |
| Dec 2004 | $16.13 B(+5.1%) | $16.13 B(+26.9%) |
| Sep 2004 | - | $12.71 B(-10.6%) |
| Jun 2004 | - | $14.22 B(-11.3%) |
| Mar 2004 | - | $16.04 B(+4.5%) |
| Dec 2003 | $15.35 B(+8.1%) | $15.35 B(+10.1%) |
| Sep 2003 | - | $13.95 B(+5.2%) |
| Jun 2003 | - | $13.26 B(-0.8%) |
| Mar 2003 | - | $13.37 B(-5.9%) |
| Dec 2002 | $14.20 B(+3.7%) | $14.20 B(+1.2%) |
| Sep 2002 | - | $14.03 B(-7.4%) |
| Jun 2002 | - | $15.15 B(+11.9%) |
| Mar 2002 | - | $13.54 B(-1.1%) |
| Dec 2001 | $13.69 B(+1.1%) | $13.69 B(+2.8%) |
| Sep 2001 | - | $13.32 B(+7.5%) |
| Jun 2001 | - | $12.39 B(-9.7%) |
| Mar 2001 | - | $13.72 B(+1.3%) |
| Dec 2000 | $13.54 B(+59.3%) | $13.54 B(+5.5%) |
| Sep 2000 | - | $12.83 B(-2.3%) |
| Jun 2000 | - | $13.14 B(-1.2%) |
| Mar 2000 | - | $13.30 B(+56.3%) |
| Dec 1999 | $8.50 B(+24.1%) | $8.50 B(+19.0%) |
| Jun 1999 | - | $7.15 B(+4.2%) |
| Dec 1998 | $6.86 B(+6.5%) | $6.86 B(+16.4%) |
| Jun 1998 | - | $5.89 B(-8.5%) |
| Dec 1997 | $6.44 B(-8.8%) | $6.44 B(-8.8%) |
| Dec 1996 | $7.06 B(-16.7%) | $7.06 B(+39.7%) |
| Dec 1995 | $8.48 B(+67.8%) | - |
| Jun 1995 | - | $5.05 B(+54.0%) |
| Jun 1995 | $5.05 B(+54.0%) | - |
| Jun 1994 | $3.28 B(-1.1%) | $3.28 B(-1.1%) |
| Jun 1993 | $3.32 B(+11.4%) | $3.32 B(+11.4%) |
| Jun 1992 | $2.98 B(-9.4%) | $2.98 B(-9.4%) |
| Jun 1991 | $3.29 B(+34.2%) | $3.29 B(+34.2%) |
| Jun 1990 | $2.45 B(+83.2%) | $2.45 B(+83.2%) |
| Jun 1989 | $1.34 B(-9.9%) | $1.34 B(-9.9%) |
| Jun 1988 | $1.48 B(+29.7%) | $1.48 B(+29.7%) |
| Jun 1987 | $1.14 B(+33.8%) | $1.14 B(+33.8%) |
| Jun 1986 | $855.56 M(+52.6%) | $855.56 M |
| Jun 1985 | $560.59 M(+1.2%) | - |
| Jun 1984 | $553.91 M | - |
FAQ
- What is GSK annual total current liabilities?
- What is the all time high annual current liabilities for GSK?
- What is GSK annual current liabilities year-on-year change?
- What is GSK quarterly total current liabilities?
- What is the all time high quarterly current liabilities for GSK?
- What is GSK quarterly current liabilities year-on-year change?
What is GSK annual total current liabilities?
The current annual current liabilities of GSK is $27.23 B
What is the all time high annual current liabilities for GSK?
GSK all-time high annual total current liabilities is $35.91 B
What is GSK annual current liabilities year-on-year change?
Over the past year, GSK annual total current liabilities has changed by +$386.65 M (+1.44%)
What is GSK quarterly total current liabilities?
The current quarterly current liabilities of GSK is $27.23 B
What is the all time high quarterly current liabilities for GSK?
GSK all-time high quarterly total current liabilities is $45.89 B
What is GSK quarterly current liabilities year-on-year change?
Over the past year, GSK quarterly total current liabilities has changed by $0.00 (0.00%)